Bio

Mark Junewicz founded Junewicz & Co. in 1990 to focus on providing senior-level financial advisory services to small and mid-cap companies in the Life Sciences industry. Prior to that he was a Managing Director in investment banking at two major Wall Street firms – Merrill Lynch and Bear Stearns. At Merrill Lynch, he served as senior investment banker to a number of large companies including Schering-Plough, IBM, Deere and Time-Warner. Mark led teams advising clients on both financing and strategic alternatives and executed over 200 successful transactions. He was also responsible for training all newly-hired investment banking associates. Over his investment banking career, Mark has advised a broad range of companies from start-ups to Fortune 500 companies. He has worked with a number of emerging growth companies on their IPOs and equity-related securities offerings and strategic transactions. Mark provides a level of experience, industry knowledge and contacts, and transaction skills not generally available to small and mid-cap Life Sciences companies. Mark is relationship-oriented and has put his clients first for his entire investment banking career, both at Junewicz & Co. and before. Mark received a B.S., cum laude, in Economics and an M.B.A. from The Wharton School of the University of Pennsylvania. While at Wharton Graduate, Mark was a teaching assistant in the Accounting Department. Mark is an Executive in Residence at Mount Sinai Innovation Partners, the tech transfer arm of the Icahn School of Medicine at Mount Sinai. He is also a Senior Advisor to Brookline Capital Markets. Mark was previously a member of the Advisory Board of Ignyta, Inc., a developer of precision therapeutics for cancer treatment, which was acquired in February 2018 by Roche Holdings AG. A former Division I college golfer, Mark is also Co-Chairman of the University of Pennsylvania Athletics Golf Sports Board.